A COVID-19 patient currently undergoing treatment at Sungai Buloh Hospital will be the first patient in Southeast Asia to be administered the antiviral drug Remdesivir. The patient is the first of a hundred to be recruited for clinical trials from hospitals nationwide under the World Health Organisation (WHO). Remdesivir is developed by American biotechnology company … Continue reading Sg Buloh Hospital COVID-19 patient first in SEA to be given trial drug Remdesivir